rx 821002 has been researched along with nisoxetine in 3 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (nisoxetine) | Trials (nisoxetine) | Recent Studies (post-2010) (nisoxetine) |
---|---|---|---|---|---|
317 | 0 | 45 | 316 | 2 | 62 |
Protein | Taxonomy | rx 821002 (IC50) | nisoxetine (IC50) |
---|---|---|---|
Cytochrome P450 1A1 | Homo sapiens (human) | 0.0079 | |
Cytochrome P450 1A2 | Homo sapiens (human) | 0.0079 | |
Prostaglandin G/H synthase 1 | Homo sapiens (human) | 2.4 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0131 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0083 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.8628 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.65 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Greenup, JL; Leverenz, JB; Peskind, ER; Raskind, MA; Szot, P; White, SS | 1 |
Beveridge, TJ; Nader, MA; Porrino, LJ; Smith, HR | 1 |
García-Fuster, MJ; García-Sevilla, JA | 1 |
3 other study(ies) available for rx 821002 and nisoxetine
Article | Year |
---|---|
Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Dendrites; Female; Fluoxetine; Hippocampus; Humans; Idazoxan; In Situ Hybridization; Lewy Body Disease; Locus Coeruleus; Male; Middle Aged; Nerve Tissue Proteins; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Prazosin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; RNA, Messenger; Tetralones; Tyrosine 3-Monooxygenase | 2006 |
Effects of abstinence from chronic cocaine self-administration on nonhuman primate dorsal and ventral noradrenergic bundle terminal field structures.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Autoradiography; Brain; Cocaine; Cocaine-Related Disorders; Fluoxetine; Idazoxan; Macaca mulatta; Male; Neural Pathways; Norepinephrine Plasma Membrane Transport Proteins; Receptors, Adrenergic, alpha-2; Reinforcement Schedule; Self Administration | 2016 |
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Apoptosis; Autoreceptors; Blotting, Western; Brain; CASP8 and FADD-Like Apoptosis Regulating Protein; Cerebral Cortex; Clorgyline; Desipramine; Electroshock; Excitatory Amino Acid Antagonists; Fas-Associated Death Domain Protein; Fluoxetine; Idazoxan; Indans; Ketamine; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Phosphoproteins; Phosphorylation; Rats; RNA-Binding Proteins; Thiazoles | 2016 |